Key Takeaways Retatrutide is not FDA approved as of May 2026
PlexusDx does not sell or ship branded prescription medications
The FDAs action followed numerous reports through the FAERS database of patients experiencing severe intestinal complications requiring emergency surgery, with some cases resulting in bowel perforation, sepsis, and death
Compounded semaglutide, with its unique selling points of cost-effectiveness and accessibility, is gaining popularity as a weight loss solution
Surgical-Level Results: Latest 2026 data shows an average weight loss of 28.7% to 30% over 68 weeksmatching the efficacy of some bariatric surgeries
Before placing an order, researchers should clear the material through their institution's ethics committee, COSHH (Control of Substances Hazardous to Health) assessment, and local biosafety policy